In fact, a study by Falus et al. (1983) demonstrated significantly higher beta-2-microglobulin levels in FS patients compared to those with joint-restricted RA, which further supports this biomarker’s role in FS diagnosis [7]. Here, B2M is linked to rheumatoid arthritis.